Award

U10 CA021661

Funded outputs count: 346

Funder award ID: U10 CA021661

OpenAlex ID: G4635459854

Long-Term Feeding Tube Use in Head and Neck Cancer Survivors—An Analysis of Patient- and Treatment-Related Factors

2025 · Thomas J. Galloway, Stephanie L. Pugh, et al. · International Journal of Radiation Oncology*Biology*Physics · 2

Long-Term Analysis of NRG Oncology RTOG 0415: A Randomized Phase III Noninferiority Study Comparing Two Fractionation Schedules in Patients With Low-Risk Prostate Cancer

2024 · W. Robert Lee, James J. Dignam, et al. · Journal of Clinical Oncology · 52

PDF

Concurrent Chemotherapy and Pelvic Radiation Therapy Compared With Pelvic Radiation Therapy Alone as Adjuvant Therapy After Radical Surgery in High-Risk Early-Stage Cancer of the Cervix

2023 · William A. Peters, P.Y. Liu, et al. · Journal of Clinical Oncology · 101

Federated learning enables big data for rare cancer boundary detection

2022 · Sarthak Pati, Ujjwal Baid, et al. · Nature Communications · 388

PDF

Quality of Life Implications of Dose-Escalated External Beam Radiation for Localized Prostate Cancer: Results of a Prospective Randomized Phase 3 Clinical Trial, NRG/RTOG 0126

2021 · William A. Hall, Snehal Deshmukh, et al. · International Journal of Radiation Oncology*Biology*Physics · 16

External validation of a shortened screening tool using individual participant data meta-analysis: A case study of the Patient Health Questionnaire-Dep-4

2021 · Daphna Harel, Brooke Levis, et al. · Methods · 8

Addition of Metformin to Concurrent Chemoradiation in Patients With Locally Advanced Non–Small Cell Lung Cancer

2021 · Heath Skinner, Chen Hu, et al. · JAMA Oncology · 96

PDF

Psychological Treatment for Patients Receiving Radiation: Results of NRG Oncology/RTOG 0841

2021 · William Small, Stephanie L. Pugh, et al. · International Journal of Radiation Oncology*Biology*Physics · 4

Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade Glioma

2020 · Erica H. Bell, Peixin Zhang, et al. · Journal of Clinical Oncology · 221

Patient Health Questionnaire-9 scores do not accurately estimate depression prevalence: individual participant data meta-analysis

2020 · Brooke Levis, Andrea Benedetti, et al. · Journal of Clinical Epidemiology · 217

PDF

Improvement in Patient-Reported Outcomes With Intensity-Modulated Radiotherapy (RT) Compared With Standard RT: A Report From the NRG Oncology RTOG 1203 Study

2020 · Anamaria R. Yeung, Stephanie L. Pugh, et al. · Journal of Clinical Oncology · 132

Results of the NRG Oncology/RTOG 0848 Adjuvant Chemotherapy Question—Erlotinib+Gemcitabine for Resected Cancer of the Pancreatic Head

2020 · Ross A. Abrams, Kathryn A. Winter, et al. · American Journal of Clinical Oncology · 64

Prostate-Specific Antigen After Neoadjuvant Androgen Suppression in Prostate Cancer Patients Receiving Short-Term Androgen Suppression and External Beam Radiation Therapy: Pooled Analysis of Four NRG Oncology Radiation Therapy Oncology Group Randomized Clinical Trials

2019 · Christopher L. Hallemeier, Peixin Zhang, et al. · International Journal of Radiation Oncology*Biology*Physics · 13

Validation of NRG oncology/RTOG‐0129 risk groups for HPV‐positive and HPV‐negative oropharyngeal squamous cell cancer: Implications for risk‐based therapeutic intensity trials

2019 · Carole Fakhry, Qiang Zhang, et al. · Cancer · 85

PDF

Effect of Chemotherapy With Docetaxel With Androgen Suppression and Radiotherapy for Localized High-Risk Prostate Cancer: The Randomized Phase III NRG Oncology RTOG 0521 Trial

2019 · Seth A. Rosenthal, Chen Hu, et al. · Journal of Clinical Oncology · 150

Multi-Institutional Validation of a Knowledge-Based Planning Model for Patients Enrolled in RTOG 0617: Implications for Plan Quality Controls in Cooperative Group Trials

2018 · James A. Kavanaugh, Sarah Holler, et al. · Practical Radiation Oncology · 36

Randomized phase II/III confirmatory treatment selection design with a change of survival end points: Statistical design of Radiation Therapy Oncology Group 1216

2018 · Qiang (Ed) Zhang, Qian Wu, et al. · Head & Neck · 20

Time Interval to Biochemical Failure as a Surrogate End Point in Locally Advanced Prostate Cancer: Analysis of Randomized Trial NRG/RTOG 9202

2018 · James J. Dignam, Daniel A. Hamstra, et al. · Journal of Clinical Oncology · 32

The association of health-related quality of life and cognitive function in patients receiving memantine for the prevention of cognitive dysfunction during whole-brain radiotherapy

2018 · Nadia N Laack, Stephanie L Pugh, et al. · Neuro-Oncology Practice · 19

PDF

Phase 2 Study of Radiation Therapy Plus Low-Dose Temozolomide Followed by Temozolomide and Irinotecan for Glioblastoma: NRG Oncology RTOG Trial 0420

2018 · Frank S. Lieberman, Meihua Wang, et al. · International Journal of Radiation Oncology*Biology*Physics · 14

Interreader Variability of Dynamic Contrast-enhanced MRI of Recurrent Glioblastoma: The Multicenter ACRIN 6677/RTOG 0625 Study

2018 · Daniel P. Barboriak, Zheng Zhang, et al. · Radiology · 26

Feasibility of Implementing the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in a Multicenter Trial: NCCTG N1048

2018 · Ethan Basch, Amylou C. Dueck, et al. · Journal of Clinical Oncology · 76

PDF

Randomized phase III trial to evaluate radiopharmaceuticals and zoledronic acid in the palliation of osteoblastic metastases from lung, breast, and prostate cancer: report of the NRG Oncology RTOG 0517 trial

2018 · for the NRG Oncology, Michael J. Seider, et al. · Annals of Nuclear Medicine · 13

Attrition in NRG Oncology's Radiation-Based Clinical Trials

2018 · Connie M. Ulrich, Snehal Deshmukh, et al. · International Journal of Radiation Oncology*Biology*Physics · 3

Prognostic value of contrast enhancement and FLAIR for survival in newly diagnosed glioblastoma treated with and without bevacizumab: results from ACRIN 6686

2018 · Jerrold L Boxerman, Zheng Zhang, et al. · Neuro-Oncology · 35

PDF